Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brinkman L, Aslander MM, Raajimakers JA, Lammers JW, Koenderman L, Bruijnzeel-Koomen CA (1997) Bronchial and cutaneous responses in atopic dermatitis patients after allergen inhalation challenge. Clin Exp Allergy 27:1043–1051
Marin A, Eseverri JL, Botey J (1998) From atopic dermatitis to asthma. Allergo Immunopathol (Madr) 26:114–119
Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola M (2000) From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161:1720–1745
Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Selroos O, Sovijärvi A, Stenius-Aarniala B, Svahn T, Tammivaara R, Laitinen LA (1994) Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 331: 700–705
Haahtela T, Heiskala M, Suoniemi I (1980) Allergic disorders and immediate skin test reactivity in Finnish adolescents. Allergy 35:433–441
Bousquet J, Dutau G, Grimfeld A, de Prost Y (eds) (2002) From atopic dermatitis to asthma. Expansion Scientifique Francaise, Paris
Salob SP, Atherton DJ (1993) Prevalence of respiratory symptoms in children with atopic dermatitis attending pediatric dermatology clinics. Pediatrics 91:8–12
Salob SP, Laverty A, Atherton DJ (1993) Bronchial hyperresponsiveness in children with atopic dermatitis. Pediatrics 91:13–16
Barker AF, Hirshman CA, D’silva R, Hanifin JM (1991) Airway responsiveness in atopic dermatitis. J Allergy Clin Immunol 87:780–783
Kjellman NIM, Nilsson L (1998) From food allergy and atopic dermatitis to respiratory allergy. Pediatr Allergy Immunol 9[Suppl 11]:13–17
Kjellman B, Hattevig G (1994) Allergy in early and late onset of atopic dermatitis. Acta Paediatr 83:229–231
Sigurs N, Hattevig G, Kjellman NIM, Nilsson L, Björksten B (1994) Appearance of atopic disease in relation to serum IgE antibodies in children followed up from birth to 15 years. J Allergy Clin Immunol 94:757–763
Queille-Roussel C, Raynaud F, Saurat JH (1985) A prospective computerized study of 500 cases of atopic dermatitis in childhood. Acta Dermatol Venereol (Stockh) 114[Suppl]:87–92
Rystedt I (1985) Prognosis factors in atopic dermatitis. Acta Dermatol Venereol (Stockh) 65:206–213
Linna O, Kokkonen J, Lahtela P, Tammela O (1992) Ten-year prognosis for generalized infantile eczema. Acta Paediatr 81:1013–1016
Kayahara M, Murakami G, Adachi Y, Matsuno M, Onoue Y, Iwaya M, Takayanagi M, Ikarashi T (1994) Bronchial hypersensitivity and development of bronchial asthma in children with atopic dermatitis. Arerug 43:759–765
Crockcroft DW, Murdock KY, Berscheid BA (1984) Relationship between atopy and bronchial responsiveness to histamine in a random population. Ann Allergy 53:26–29
Corbo GM, Ferrante E, Macciocchi B, Foresi A, De Angelis V, Fabbri L, Ciappi G (1989) Bronchial hyperresponsiveness in atopic dermatitis. Allergy 44:595–598
Fabrizi G, Corbo GM, Ferrante E, Macciocchi B, De Angelis V, Romano A, Agabiti N, De Vicuna EG, Vultaggio P, Abgelini E et al (1992) The relationship between allergy, clinical symptoms and bronchial responsiveness in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 176:68–73
Schauer U, Trube M, Jager R, Gieler U, Rieger CH (1995) Blood eosinophils, eosinophil-derived proteins, and leukotriene C4 generation in relation to bronchial hyperreactivity in children with atopic dermatitis. Allergy 50:126–132
Brinkman L, Raaijmakers JA, Bruijnzeel-Koomen CA, Koenderman L, Lammers JW (1997) Bronchial and skin reactivity in asthmatic patients with and without atopic dermatitis. Eur Respir J 10:1033–1040
ETAC Study Group (1998) Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Pediatr Allergy Immunol 9:116–124
Warner JO (2001) A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months’ treatment and 18 months’ posttreatment follow-up. J Allergy Clin Immunol 108:929–937
Iikura Y, Naspitz CK, Mikawa H, Talaricoficho S, Baba M, Sole D, Nishima S (1992) Prevention of asthma by ketotifen in infants with atopic dermatitis. Ann Allergy 68:233–236
Bustos GJ, Bustos D, Romero D (1995) Prevention of asthma with ketotifen in pre-asthmatic children: a three-year follow-up study. Clin Exp Allergy 25:568–573
Moller C, Dreborg S, Ferdousi HA, Halken S, Host A, Jacobsen L, Koivikko A, Koller DY, Niggemann B, Norberg LA, Urbanek R, Valovirta E, Wahn U (2002) Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT study). J Allergy Clin Immunol 109:251–256
Agertoft L, Pedersen S (1994) Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 88: 373–381
Turpeinen M, the HEICA Study Group (2000) Helsinki Early Intervention Childhood Asthma (HEICA) study: inhaled budesonide halved the number of asthma exacerbations compared with disodium cromoglycate during 18 months of treatment. Eur Respir J 16:824–830
Rytilä P, Metso T, Heikkinen K, Saarelainen P, Helenius I, Haahtela T (2000) Airway inflammation in patients with symptoms suggesting asthma but with normal lung function. Eur Respir J 16:824–830
Panhuysen CI, Vonk JM, Koeter GH, Schouten JP, van Altena R, Bleecker ER, Postma DS (1997) Adult patients may outgrow their asthma: a 25-year follow-up study. Am J Respir Crit Care Med 155:1267–1272
Haahtela T (1999) Early treatment of asthma. Allergy 54[Suppl 49]: 74–81
Puolijoki H, Lahdensuo A (1987) Chronic cough as a risk indicator of broncho-pulmonary disease. Eur J Respir Dis 71:77–85
Remes ST, Korppi M, Remes K (1998) Outcome of children with respiratory symptoms without objective evidence of asthma: a two-year, prospective, follow-up study. Acta Paediatr 87:165–168
Oswald H, Phelan PD, Lanigan A, Hibbert M, Carlin JB, Bowes G, Olinsky A (1997) Childhood asthma and lung function in mid-adult life. Pediatr Pulmonol 23:14–20
Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Reinikainen K, Selroos O, Sovijärvi A, Stenius-Aarniala B, Svahn T, Tammivaara R, Laitinen LA (1991) Comparison of a B2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 325:388–392
Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, Ullman A, Lamm CJ, O’Byrne PM START Investigators Group (2003) Early intervention inmild persistent asthma: a randomized double-blind study. Lancet 361:1066–1067
Hargreave FE, Leigh R (1999) Induced sputum, eosinophilic bronchitis, and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160: S53–S57
Pin I, Gibson PG, Kolendowicz R et al (1992) Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 47:697–704
Pizzichini E, Pizzichini MMM, Efthimiadis A, Dolovich J, Hargreave FE (1997) Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. J Allergy Clin Immunol 99:539–544
Sorva R, Metso T, Turpeinen M, Juntunen-Backman K, Björksten F, Haahtela T (1997) Eosinophil cationic protein in induced sputum as a marker of inflammation in asthmatic children. Pediatr Allergy Immunol 8:45–50
Metso T, Venge P, Peterson C, Haahtela T, Seveus L (2002) Cell-specific markers for eosinophils and neutrophils in sputum and bronchoalveolar lavage of patients with respiratory conditions and healthy subjects. Thorax 57:449–451
Carlson MG, Peterson CG, Venge P (1985) Human eosinophil peroxidase: purification and characterization. J Immunol 134:1875–1879
Xu SY, Petersson CG, Carlson M, Venge P (1994) The development of an assay for human neutrophil lipocalin (HNL) — to be used as a specific marker of neutrophil activity in vivo and vitro. J Immunol Methods 171:245–252
Helenius IJ, Rytila P, Metso T, Haahtela T, Venge P, Tikkanen HO (1998) Respiratory symptoms, bronchial responsiveness, and cellular characteristics of induced sputum in elite swimmers. Allergy 53:346–352
Metso T, Rytilä P, Peterson C, Haahtela T (2001) Granulocyte markers in induced sputum in patients with respiratory disorders and healthy persons obtained by two sputum processing methods. Respir Med 95:48–55
Kharitonov SA, Barnes PJ (2001) Does exhaled nitric oxide reflect asthma control? Yes, it does! Am J Respir Crit Care Med 164:727–728
Van Den Toorn LM, Overbeek SE, De Jongste JC, Leman K, Hoogsteden HC, Prins JB (2001) Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 164: 2107–2113
Ministry of Social Affairs and Health (1996) Asthma Programme in Finland 1994–2004. Clin Exp Allergy Suppl 1: 1–24
Global Initiative for Asthma (2002) Global Strategy for Asthma Management and Prevention. National Institutes of Health. National Heart, Lung, and Blood Insititute
Barnes J (2001) Cytokine-directed therapies for asthma. J Allergy Clin Immunol 108[Suppl 2]:S72–S76
Milgrom H, Fick RB Jr, Su JQ, Reimann JD, Bush RK, Watrous ML, Metzger WJ (1999) Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. N Engl J Med 341:1966–1973
Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P (2001) Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics 108:E36
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Haahtela, T. (2006). Respiratory Symptoms in Atopic Eczema — Focus on Asthma and Early Treatment. In: Ring, J., Przybilla, B., Ruzicka, T. (eds) Handbook of Atopic Eczema. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29856-8_11
Download citation
DOI: https://doi.org/10.1007/3-540-29856-8_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23133-2
Online ISBN: 978-3-540-29856-4
eBook Packages: MedicineMedicine (R0)